The history of Viagra and its impact on the pharmaceutical sector presents a challenging question regarding its continued attractiveness as an investment. Initially a phenomenal success, generating billions , generic competition has substantially eroded financial returns. While established pharmaceutical firms continue patents on related therapies

The trajectory of companies tied to blockbuster drugs like Viagra presents a challenging investment picture. While the initial rise of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the patent expiration in key territories has introduced substantial uncertainty . Investors are now grappling with the effect of